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Abstract 
Plants are an excellent source of drug leads. However availability is limited by 
access to source species, low abundance and recalcitrance to chemical synthesis. 
Although plant genomics is yielding a wealth of genes for natural product 
biosynthesis, the translation of this genetic information into small molecules for 
evaluation as drug leads represents a major bottleneck.  For example, the yeast 
platform for artemisinic acid production is estimated to have taken >150 person 
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years to develop. Here we demonstrate the power of plant transient transfection 
technology for rapid, scalable biosynthesis and isolation of triterpenes, one of the 
largest and most structurally diverse families of plant natural products. Using 
pathway engineering and improved agro-infiltration methodology we are able to 
generate gram-scale quantities of purified triterpene in just a few weeks. In contrast 
to heterologous expression in microbes, this system does not depend on re-
engineering of the host.  We next exploit agro-infection for quick and easy 
combinatorial biosynthesis without the need for generation of multi-gene constructs, 
so affording an easy entrée to suites of molecules, some new-to-nature, that are 
recalcitrant to chemical synthesis. We use this platform to purify a suite of bespoke 
triterpene analogs and demonstrate differences in anti-proliferative and anti-
inflammatory activity in bioassays, providing proof of concept of this system for 
accessing and evaluating medicinally important bioactives.  Together with new 
genome mining algorithms for plant pathway discovery and advances in plant 
synthetic biology, this advance provides new routes to synthesize and access 
previously inaccessible natural products and analogs and has the potential to 
reinvigorate drug discovery pipelines. 
Keywords 
Transient plant expression technology; synthetic biology; terpenes; triterpenoids; 
combinatorial biosynthesis; drug discovery.  
Abbreviations 
CPMV, cowpea mosaic virus; CYP, cytochrome P450; ELISA, enzyme-Linked 
ImmunoSorbent Assay;  EpHβA, 12,13β-epoxy,16β-hydroxy-β-amyrin; FPP, farnesyl 
diphosphate; FPS, farnesyl diphosphate synthase; GFP, green fluorescent protein; 
3 
 
HMGR, 3-hydroxy,3-methylglutaryl-CoA reductase; HT, hyper-translatable; LPS, 
lipopolysaccharide; Nrf2, nuclear factor erythroid 2 related factor 2; SAD1, Avena 
strigosa β-amyrin synthase; SQE, squalene epoxidase; SQS, squalene synthase; 
tHMGR, truncated HMGR; TIC, total ion chromatogram; TNFα, tumor necrosis factor 
alpha. 
1. Introduction 
The Plant Kingdom harbors an enormous reservoir of diverse chemicals. Accessing 
these molecules promises to reinvigorate drug discovery pipelines and provide novel 
routes to synthesize complex compounds that are beyond the reach of synthetic 
chemistry (Anarat-Cappillino and Sattely, 2014). Although breakthroughs in DNA 
sequencing technology and bioinformatics have accelerated discovery of candidate 
genes for new natural product pathways, effective harnessing of plant metabolic 
diversity will require: i) a quick and easy method to rapidly screen combinations of 
enzyme-encoding genes for production of novel structures by expression in a 
suitable heterologous host, and ii) the capability to purify suites of structural variants 
of these compounds in sufficient quantities for evaluation in bioactivity assays.   
Microorganisms, particularly yeasts, have proven to be useful heterologous hosts for 
expression of several plant natural product pathways, including the artemisinin 
precursor artemisinic acid (Paddon et al., 2013), opioids (DeLoache et al., 2015; 
Galanie et al., 2015; Li and Smolke, 2016) and monoterpene indole alkaloids (Brown 
et al., 2015; Qu et al., 2015), and can be used for industrial-scale production of high-
value plant products.  However, despite some successes, many metabolites have 
only been produced at low levels in yeasts and optimization is far from trivial.  For 
example, the development of a yeast platform for the production of artemisinic acid is 
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estimated to have taken more than 150 person years (Kwok, 2010). Making 
microbes into efficient factories for the production of heterologous metabolites is 
hindered by lack of fundamental knowledge about cellular processes (Nielsen and 
Keasling, 2016). 
Plants have a number of advantages as heterologous hosts for metabolic 
engineering. They require only simple inorganic nutrients, water, carbon dioxide and 
sunlight for efficient growth. They are also more amenable to expression of genes of 
plant origin than microbes since they support correct mRNA and protein processing, 
protein localisation and metabolic compartmentalisation, and already have many of 
the necessary metabolic precursors and co-enzymes. Species of tobacco are 
relatively easy and fast to transform by the integration of new genes into the genome 
but high yields can also be achieved in just a few days through transient expression 
following infiltration into the leaves of a culture of Agrobacterium tumefaciens 
carrying genes of interest on a binary plasmid vector, a process commonly known as 
agro-infiltration. Nicotiana benthamiana, a wild relative of tobacco, is particularly 
amenable to agro-infiltration-mediated transient expression and is currently being 
used for commercial production of flu vaccines (Marsian and Lomonossoff, 2016). 
The expression process is rapid, taking only 5-6 days from infiltration of leaves with 
A. tumefaciens strains harboring expression constructs to extraction of plant tissue. 
Importantly, combinations of genes can be co-expressed without the need for 
making multi-gene vectors simply by co-infiltrating multiple A. tumefaciens strains 
containing different expression constructs. Although various plant natural product 
pathways have previously been engineered by transient expression in this plant 
(Andersen-Ranberg et al. 2016; Geisler et al., 2013; Geu-Flores et al., 2009; 
Khakimov et al., 2015; Miettinen et al., 2014; Polturak et al., 2016; Rajniak et al., 
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2015; Wang et al., 2016), the levels achieved are usually in the microgram range.  
Here, we have optimized the N. benthamiana platform for production of up to gram-
scale amounts of purified triterpene, and have demonstrated the power of this 
transient expression system for rapid and facile combinatorial biosynthesis by 
generating over 40 different types of oxygenated triterpene analogs. We further show 
the potential of this strategy for investigating structure-activity relationships in 
bioassays. This overall strategy will greatly accelerate systematic investigation of the 
vast array of triterpene diversity found in the Plant Kingdom by enabling the outputs 
of plant genomics to be translated into purified compounds for evaluation as drug 
leads and for other applications.   
 
1. Results and discussion 
1.1. Pathway engineering for increased triterpene yield in N. benthamiana  
The triterpenes are one of the largest classes of plant natural products (>20,000 
reported to date) and are of considerable interest as potential drug leads (Hill and 
Connolly, 2012; Moses et al., 2014a).  However few hypotheses exist regarding links 
between structure and activity because of the lack of available suites of structural 
analogues for bioactivity evaluation.  These compounds are synthesized from the 
mevalonate pathway by cyclisation of the isoprenoid precursor 2,3-oxidosqualene to 
diverse triterpene scaffolds, the most common of which is β-amyrin (Thimmappa et 
al., 2014) (Fig. 1a). These scaffolds are then further modified by cytochromes P450 
(CYPs) and other tailoring enzymes.  Although yeast has been used as a 
heterologous expression host to make and modify triterpene scaffolds (Fukushima et 
al., 2013; Moses et al., 2014b; Thimmappa et al., 2014) the potential of in planta 
production has not been fully explored. We previously showed that transient 
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expression of the oat β-amyrin synthase SAD1 in N. benthamiana leads to 
accumulation of β-amyrin in infiltrated leaf tissue (Geisler et al., 2013).  Since 
precursor availability may be limiting, we co-expressed SAD1 with different upstream 
mevalonate pathway genes to determine the effects on triterpene production. 
Farnesyl pyrophosphate synthase (FPS) and squalene epoxidase (SQE) had little or 
no effect on β-amyrin content, while squalene synthase (SQS) gave a modest 
increase (Fig. 1b). The largest effect was seen with a feedback-insensitive version of 
HMG-CoA reductase (tHMGR), which gave a four-fold increase (Fig. 1b, c; Fig S1). 
CYP51H10 oxygenates β-amyrin at two positions to give 12,13-epoxy, 16-hydroxy-β-
amyrin (EpHβA) (Fig. 1d) (Geisler et al., 2013). We used this CYP to evaluate the 
effects of co-expression with tHMGR on production of oxidized triterpene scaffolds 
by expressing SAD1 and CYP51H10 in N. benthamiana leaves with or without 
tHMGR, and showed that inclusion of tHMGR led to an increase in EpHβA 
production of ~10-fold (Fig. 1e,f; Fig S1). Thus, co-expression with tHMGR proved 
sufficient to significantly increase triterpene production in this transient plant 
expression system.   
 
1.2. Gram-scale triterpene production using vacuum infiltration 
We next used tHMGR in combination with Sad1 to investigate the potential of the 
transient plant expression platform for preparative-scale triterpene production.  Our 
experiments up to this point had relied on infiltration of N. benthamiana leaves with 
A. tumefaciens cells using a syringe without a needle. To increase our capacity for 
effective leaf infiltration we designed a device that would enable efficient vacuum 
infiltration of 4-6 plants simultaneously (Fig. 2a). Preliminary experiments using a 
reporter construct showed that this method resulted in very good GFP expression in 
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infiltrated leaves (Fig. 2b). We then carried out batch-wise infiltration of ~460 N. 
benthamiana plants with a mixture of two A. tumefaciens strains carrying CPMV-HT 
expression constructs for the tHMGR and Sad1 genes, respectively, and 
purified >800 mg of β-amyrin as white needles (Fig. 2c). The crystals were estimated 
to have a purity of >98% by HPLC-CAD (Fig S2a).  Given that the mother liquor still 
contained >150 mg of β-amyrin (Fig S2b), we estimate the total amount of β-amyrin 
recovered to be in the region of one gram, which corresponds to 0.4% dry leaf 
weight. These results demonstrate the potential of the N. benthamiana transient 
expression system for preparative-scale biosynthesis, with the opportunity for further 
scale-up, for instance by using larger vacuum infiltration devices. 
 
1.3. Combinatorial biosynthesis using agro-infiltration provides rapid access to 
novel molecular diversity 
Selective functionalization of triterpene scaffolds using synthetic chemistry is limited 
by lack of available reactive groups. Within the last few years considerable advances 
have been made in identifying and characterizing triterpene biosynthetic enzymes 
from plants (Biazzi et al., 2015; Boutanaev et al., 2015; Carelli et al., 2011; 
Fukushima et al., 2011; Fukushima et al., 2013; Geisler et al., 2013; Itkin et al., 
2016; Khakimov et al., 2015; Miettinen et al., 2017; Moses et al., 2014b; Moses et 
al., 2014c; Moses et al., 2015a; Moses et al., 2015b; Salmon et al., 2016; Seki et al., 
2008; Seki et al., 2015; Shang et al., 2014; Shibuya et al., 2006; Thimmappa et al., 
2014; Yasumoto et al., 2016; Zhang et al., 2016), opening up opportunities to 
harness enzymes from nature for systematic investigation of a much broader sector 
of biologically relevant chemical space than can be achieved using conventional 
chemistry.   
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Since agro-infiltration enables co-expression of genes of interest without the need to 
make multi-gene constructs through co-infiltration of A. tumefaciens strains harboring 
different expression constructs, we evaluated the potential of the transient N. 
benthamiana expression system for combinatorial biosynthesis. We selected five 
CYPs from diverse plant species (oat, licorice, soy bean, barrelclover) that had 
previously been shown to oxidase β-amyrin at different scaffold positions (Carelli et 
al., 2011; Fukushima et al., 2011; Geisler et al., 2013; Moses et al., 2014c; Seki et 
al., 2008; Shibuya et al., 2006) and co-expressed each of these with tHMGR and 
SAD1 in N. benthamiana.  All were functional and most converted the majority of 
available β-amyrin to the expected products (Fig. 3, blue circle; Fig S3). We then 
evaluated all ten possible pairwise combinations of these CYPs for further scaffold 
modification.  A total of 41 products were detected across the different combinations 
(Figs S4-13; Table S1), many of which represented previously unreported structures. 
The major products generated are shown in Fig. 3.  Compounds 7-10 were as 
predicted based on the known activities of the enzymes and matched the respective 
electron ionization spectra of previously reported triterpenes (Table S1; Figs S4-7). 
Compounds 11-17 were purified in quantities of 3.5 - 46 mg (Table S2) and their 
structures determined by NMR following initial GC-MS analysis (Figs S8-12; Tables 
S3-8). Two of these structures had previously been reported, whilst to our knowledge 
the other five had not (Table S1). These novel triterpenes included a C12β-hydroxyl, 
C13-C28-γ-lactone generated by co-expressing CYP51H10 with CYP716A12 
(compound 17; Fig. 3), a product that has presumably arisen through intramolecular 
reactivity of the introduced functional groups. These examples illustrate the power of 
this highly versatile approach for rapid combinatorial expression and the potential for 
generating new molecules using biosynthetic enzymes from diverse plant species.   
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1.4. Preparative access to triterpene analogs allows investigation of structure-
activity relationships 
Oleanolic acid, a naturally occurring oxidized form of β-amyrin, has been used as a 
starting point to generate triterpene drug leads such as bardoxolone methyl (a potent 
activator of the Nrf2 pathway, currently in phase 2 clinical trials) using synthetic 
chemistry (Liby and Sporn, 2012). However, these initial endeavors were 
constrained by lack of oxidative functionality on the scaffold.  Using our toolkit of 
triterpene biosynthetic enzymes in combination with plant transient expression 
technology we have greatly expanded the possibility for creating diversified suites of 
oxidized variants in sufficient quantities for bioassays.  As a proof of concept, we 
assayed a series of oxygenated β-amyrin analogues that we had purified from our in 
planta expression system along with several commercially available triterpenes 
(oleanolic acid, erythrodiol, glycyrrhetinic acid) and demonstrated differences in anti-
proliferative and anti-inflammatory activity using human cell lines (Fig. 4).  Although 
the activity of these molecules was orders of magnitude lower than that of 
bardoxolone methyl, these experiments demonstrate that small differences in the 
type and position of oxidation can result in marked differences in bioactivity and open 
up opportunities to further diversify the oleanane scaffold (by further metabolic 
engineering and/or synthetic chemistry), so enabling systematic investigation of 
structure-activity relationships for pharmaceutical applications.     
2. Conclusions 
There are more than 400,000 species of flowering plants in the world. The vast 
majority of these (>99.9%) have not yet been sequenced. Over 50% of drugs in 
current use are derived from natural products (Harvey et al., 2015).  As methods for 
sequencing and mining plant genomes are becoming faster, cheaper and more 
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effective, candidate biosynthetic pathways for multitudes of new natural products will 
undoubtedly be revealed (Medema and Osbourn, 2016; Owen et al., 2017).  
Plants have many inherent advantages over microbes for expression of genes, 
enzymes and pathways of plant origin. However, they have historically been 
overlooked as efficient heterologous hosts for small molecule production, in part due 
to the technical and regulatory challenges and length of time associated with 
generation of high-level producing stable transgenic lines.  Although N. benthamiana 
has previously been used as a host for transient expression of terpene biosynthetic 
genes (primarily for mono-, di- and sesquiterpenes), the estimated levels as 
assessed by GC- or LC-based quantification of leaf extracts were in the region of 0.6 
μg – 1 mg/g dry weight.  Most of these are theoretical yields since few of these 
products were purified, which would inevitably result in significant yield loss (Table 
S11). In a proof of concept experiment we previously showed that we could purify 20 
mg of triterpene from 17 g of leaf tissue following transient expression in N. 
benthamiana (an actual yield of 1.18 mg/g dry weight) (Geisler et al., 2013).  Here 
we demonstrate optimization of this expression system through a combination of 
pathway engineering and improvement of the agro-infiltration process. We firstly 
show that inclusion of a feedback insensitive form of HMG-CoA reductase in our co-
infiltration experiments increased the yields of simple and oxidized triterpenes by 4-
10 fold.  Secondly, we develop a highly effective vacuum infiltration process and 
demonstrate that this can be used for infiltration of whole plants rather than individual 
leaves, to yield gram-scale quantities of purified triterpene.  Thirdly, we show that 
this transient expression system can be used to rapidly generate suites of purified 
triterpenes and analogs, simply by mixing A. tumefaciens strains carrying different 
expression constructs.   
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Our work demonstrates the power and potential of this novel plant transient 
transfection technology for rapid preparative access to plant-derived molecules. This 
technology, in combination with advances in commercial DNA synthesis and 
establishment of standardized methods and pipelines for modular and rapid 
construction of vectors for heterologous expression in plants using synthetic biology 
approaches (Patron et al., 2015; Owen et al. 2017), opens up unprecedented 
opportunities for harnessing new molecular diversity for drug discovery, producing 
normally low-abundance molecular entities in quantity (enablement of bioprospecting 
hits), and improving on promising natural product leads (lead optimization for 
complex biomolecules).   
3. Materials and Methods 
3.1. Generation of Gateway Entry constructs 
Oligonucleotide primers were purchased from Sigma-Aldrich and all PCR steps were 
performed using Phusion polymerase (New England Biolabs). The oat HMGR, FPS, 
SQS and SQE gene sequences were identified from an A. strigosa root tip 454 
transcriptomic database (Kemen et al., 2014) (GenBank accession numbers tHMGR 
– KY28473; FPS1 – KY28474; SQS1 – KY28475; SQE1 – KY28476). A. strigosa 
root tip RNA extraction and cDNA synthesis was performed as described previously 
(Kemen et al., 2014). The partial HMGR gene lacking the first 417 nucleotides 
(tHMGR) was amplified from this cDNA using primers P1 + P2 (Table S10) and 
cloned into the Gateway Entry vector pENTR-D-TOPO (Invitrogen) according to the 
manufacturer’s instructions. Full length coding sequences of FPS, SQS and SQE 
were amplified from cDNA by PCR using primers P3 + P4, P5 + P6 and P7 + P8 
respectively (Table S10). The amplified products were inserted into a Zero Blunt 
TOPO vector (Invitrogen) according to the manufacturer’s instructions. These 
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vectors were then used as templates for PCR to generate Gateway-compatible 
inserts using primers P9 + P10, P11 + P12 and P13 + P14 respectively (Table S10). 
The amplified products were cloned into the pDONR207 vector using BP clonase II 
enzyme mix (Invitrogen) according to the manufacturer’s instructions. SAD1 and 
CYP51H10 Gateway inserts were likewise amplified from vectors as described 
previously (Geisler et al., 2013) using the primers P15 + P16 and P17 + P18 
respectively and inserted into pDONR207 (Table S10). The full length coding 
sequence for CYP72A65 (Medtr8g042000) was amplified from M. truncatula cDNA 
using primers P19 and P20 and then inserted into pDONR221 (Thermo Fisher). All 
constructs were sequenced within the Entry vector to verify the integrity of the clones 
(performed by Eurofins Genomics). The CYP88D6 entry clone (Seki et al., 2008) was 
kindly donated by Prof. Toshiya Muranaka. Entry clones for CYP716A12 (Moses et 
al., 2014b) and CYP93E1 (Moses et al., 2014c) were used as previously described.  
Genes were cloned from the relevant Entry vectors into pEAQ-HT-DEST1 using LR 
clonase II enzyme (Invitrogen) according to the manufacturer’s instructions. An 
expression construct containing GFP in pEAQ-HT-DEST1 (Sainsbury et al., 2009) 
was kindly provided by the Lomonossoff laboratory (John Innes Centre, UK). The 
expression constructs were transformed into chemically competent Agrobacterium 
tumefaciens strain LBA4404 by flash freezing in liquid nitrogen.  
 
3.2. Agro-infiltration  
A. tumefaciens strains carrying the relevant constructs were cultured and prepared 
for infiltration as described previously (Sainsbury et al., 2012) except that the OD600 
of the cells in MMA buffer was adjusted to 0.2 x n, depending on the number of 
cultures (n) to be coinfiltrated. Bacterial suspensions were always combined in equal 
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volumes for coinfiltration. N. benthamiana plants were grown as in Sainsbury et al. 
(2012). Infiltration by syringe was performed as previously described (Sainsbury et 
al., 2012). For vacuum infiltration, the infiltration apparatus was constructed from a 
vacuum oven (LTE Scientific) which formed the infiltration chamber. The oven was 
connected to a pump via a vacuum reservoir (AVE) to reduce the time required to 
achieve the desired vacuum in the infiltration chamber. Plants were secured within a 
bespoke holder and inverted into a stainless steel water bath containing 10 L of A. 
tumefaciens suspension, ensuring that the aerial parts were completely submerged. 
The water bath was sealed within the vacuum chamber, and the vacuum applied for 
approximately one minute until the pressure had been reduced by 880 mbar. The 
infiltration chamber was then quickly returned back to atmospheric pressure resulting 
in infiltration of the bacterial suspension. Infiltrated leaves were harvested after 5 
days. 
 
3.3. Quantification of β-amyrin and EpHβA in N. benthamiana leaf extracts 
Infiltrated N. benthamiana leaves were harvested and 12 mm leaf disks were 
punched and frozen at -80 °C. The disks were lyophilized, weighed and transferred 
to 2 mL GC-MS autosampler vials (Agilent). Standard solutions of β-amyrin 
(Extrasynthese) and EpHβA (this study) were made to a concentration of 0.5 mg/mL 
in EtOH and used to make ten 2-fold dilutions, which when dried gave a calibration 
series from 50 μg down to ~0.1 μg. These steps were performed using a Gerstel 
MultiPurpose Sampler (MPS) to minimize pipetting errors. A saponification solution 
(EtOH:H2O:KOH 9:1:1 v:v:w) was prepared containing the internal standard 
(coprostan-3-ol, Sigma-Aldrich) to a final concentration of 10 μg/mL. Aliquots (500 
μL) were pipetted into each sample vial (leaf disks and standards) using the Gerstel 
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MPS. Samples were incubated at 65°C for 2 h with intermittent agitation. 250 μL of 
H2O was added to each sample and vortexed before addition of 500 μL hexane. 
Samples were vortexed (2 x 10 sec) and 100 μL of the upper hexane phase 
transferred to a fresh vial and dried. GC-MS analysis was performed as described in 
section 3.5 and data analyzed using Agilent MassHunter Quantification software. 
Quantification of β-amyrin and EpHβA was achieved relative to the external standard 
calibration curves. Quantifier ions for coprostan-3-ol (370), β-amyrin (218) and 
EpHβA (189) were used. Quantification values were divided by the weight of the 
original leaf disk to calculate yield per gram of dry leaf weight. Graphs were 
constructed using GraphPad Prism (version 5). Statistics were performed using one-
way ANOVA with post-hoc analysis (Tukey’s multiple comparisons test). 
 
3.4. Combinatorial triterpene biosynthesis  
Five-week-old plants were infiltrated using three leaves per plant as replicates. For 
each combination, four A. tumefaciens strains were coinfiltrated including two 
carrying tHMGR and Sad1 along with two strains carrying the relevant CYP genes 
(where a single CYP was used, GFP was included in place of the second CYP). 
Leaves were harvested 5 days after infiltration and lyophilized. For extraction, a 
single 15 mm leaf disk was taken from each dried leaf and 500 μL EtOAc [containing 
10μg/mL coprostan-3-ol (Sigma-Aldrich)] added to each sample. Leaf tissue was 
disrupted by shaking with a single 3 mm tungsten carbide bead (Qiagen). Samples 
were incubated at room temperature with gentle shaking for 2 h. Aliquots (50 μL) 
were taken from each sample, transferred to a separate vial and dried under N2. GC-
MS analysis was performed as described in section 3.5 and samples analyzed using 
Agilent MassHunter Qualitative Analysis software. New products were identified by 
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overlaying the total ion chromatograms of the combinatorial samples with their 
relevant single CYP controls (see Figure S4-S13). A summary of the combinatorial 
biosynthesis results is provided in Table S1. 
 
3.5. GC-MS analysis of leaf extracts 
Dried samples were derivatized using Tri-Sil Z reagent (Sigma-Aldrich) and diluted in 
an equivalent volume of ethyl acetate prior to GC-MS analysis. GC was performed 
using an Agilent 7890B fitted with a Zebron ZB5-HT Inferno column (Phenomenex). 
Injections were performed in pulsed splitless mode (30 psi pulse pressure) with the 
inlet temperature set to 250°C. The GC oven temperature program was 170°C and 
held for 2 mins with subsequent increase to 300°C (20°C/min) and held at 300°C for 
an additional 11.5 min (total run time 20 min). The GC oven was coupled to an 
Agilent 5977A Mass Selective Detector set to scan mode from 60-800 mass units 
(solvent delay 8 minutes). For quantification, the detector was set to 7.2 scans/sec. 
 
3.6. Triterpene purification  
Infiltrations were performed as described in section 3.2 using six-week-old N. 
benthamiana plants. A summary of infiltrated A. tumefaciens strains, plant quantities 
and product yields is provided in Table S2. Details of purification of specific products 
are provided in Supplementary Information.  
 
3.7. NMR analysis 
NMR spectra were recorded in Fourier transform mode at a nominal frequency of 
400 MHz for 1H NMR and 100 MHz for 13C NMR, using the specified deuterated 
solvent. Chemical shifts were recorded in ppm and referenced to the residual solvent 
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peak or to an internal TMS standard. Multiplicities are described as, s = singlet, d = 
doublet, dd = doublet of doublets, dt = doublet of triplets, t = triplet, q = quartet, m = 
multiplet, br = broad, appt = apparent; coupling constants are reported in hertz as 
observed and not corrected for second order effects. NMR data are provided as 
supplementary information. 
 
3.8. Yeast strains and metabolite analysis  
Yeast strains for combinatorial biosynthesis were generated from strain PA14 
(Miettinen et al., 2017). Strain 1 (Table S9) was generated by transforming PA14 
with a yeast expression construct harboring the Glycyrrhiza glabra β-amyrin 
synthase GgbAS, the M. truncatula cytochrome P450 reductase (MTR1) and the 
truncated S. cerevisiae HMGR1, pESC-URA[GAL1/GgbAS T2A MTR1; 
GAL10/tHMG1] (Miettinen et al., 2017). For generating CYP yeast expression 
vectors, the Gateway Entry vectors carrying CYP51H10, CYP88D6, CYP72A65 and 
CYP716A12 as described in section 3.1 were used. A vector carrying the functionally 
equivalent CYP93E9 (Moses et al., 2014c) was used in place of CYP93E1. These 
were recombined into both yeast expression destination vectors pAG423GAL-ccdB 
(Addgene plasmid 14149 (Alberti et al., 2007)) and pAG425GAL-ccdB (Addgene 
plasmid 14153 (Alberti et al., 2007)). These vectors were transformed into PA14 and 
the yeast strains cultivated in the presence of methyl-β-cyclodextrins (MβCD) as 
previously described (Moses et al., 2014b). Aliquots (10 mL) of spent yeast culture 
medium were extracted twice with 5 mL hexane and then with 5 mL of ethyl acetate. 
The resulting organic extracts were pooled and evaporated to dryness. Samples 
were derivatized with 50 μL of N-methyl-N-(trimethylsilyl) trifluoroacetamide (Sigma-
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Aldrich) and 10 μL of pyridine. GC-MS analysis was carried out as previously 
described (Moses et al., 2014b). 
 
3.9. Bioactivity assays 
β-Amyrin, oleanolic acid, erythrodiol and 18β-glycyrrhetinic acid were purchased as 
dry powders from Extrasynthese. Bardoxolone-methyl was purchased as a dry 
powder from SelleckChem. Products purified from N. benthamiana were dried under 
vacuum for 24 h to ensure removal of trace solvents. Stock solutions of 10 or 20 mM 
were made in DMSO under sterile conditions. Eight two-fold serial dilutions of these 
stocks were then made (in DMSO) for use in bioassays. Sterile conditions were 
maintained throughout all subsequent experiments. HL60 and THP-1 cell lines were 
obtained from the European Collection of Authenticated Cell Cultures (ECACC). 
These were maintained in Roswell Park Memorial Institute (RPMI) 1640 media 
(Hyclone) supplemented with 10% heat inactivated bovine fetal calf serum  
(Hyclone), L-glutamine (2 mM) and antibiotics (penicillin 100 U/mL; streptomycin 
(100 μg/mL) (Gibco). Cultures were maintained at 37°C in a humidified atmosphere 
with 5% CO2 and passaged every 3.5 days. Cell densities were measured using a 
Malassez hemocytometer under a light microscope and diluted by addition of fresh 
media to the densities described below. 
 
For anti-proliferation assays, HL60 cells were seeded at a density of 3x105 cells/mL 
in 100 μL aliquots in 96 well plates (3x104 cells per well). To each 100 μL well, 1 μL 
of the test compound was added from the series of stock solutions described above 
to give the final test concentration (in the micromolar range). Each plate included 
controls of untreated cells, vehicle (DMSO)-treated controls and media only-wells. 
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Following addition of the compounds, the cells were incubated for 72 h at 37°C (with 
5% CO2). Cell proliferation was determined using a Cell Titer 96 Aqueous non-
radioactive assay; (Promega). MTS reagent was added to the wells and incubated 
for 4 h before measuring absorbance at 492 nm. Absorbance values were corrected 
by subtracting the media-only control. IC50 values were calculated using non-linear 
regression analysis performed in GraphPad Prism software (version 5). 
 
For the anti-inflammatory assays, THP-1 cells were seeded at a density of 1x106 
cells/mL in 500 μL aliquots (5x105 cells per well). Test compounds (100 μM aliquots) 
were added to the appropriate wells and the cells incubated for 30 min at 37°C (5% 
CO2). After this time, 1 μL of LPS (Merck Millipore) was added (from a 0.5mg/mL 
stock solution in RPMI medium) to the appropriate wells to stimulate TNFα 
production. The cells were incubated for a further 3 h before pelleting by 
centrifugation (2000 rpm, 5 min). Supernatants were harvested, transferred to fresh 
tubes on ice, and stored at -80°C until needed. The TNFα ELISA was performed 
using a Human TNF ELISA kit (BD Biosciences) according to the manufacturer’s 
instructions. Aliquots (100μL) of the supernatants (diluted 4-fold) and standards were 
added to the ELISA plate. A TNFα standard (BD Biosciences) was prepared across 
a two-fold serial dilution range from 500 pg/mL to 7.8 pg/mL (diluted in phosphate 
buffered saline solution: per liter: 8 g NaCl, 1.17 g Na2HPO4, 0.2 g KH2PO4, 0.2 g 
KCl) and used to generate a standard curve for determining TNFα production. Plates 
were incubated at room temperature for 2 h before washing and detection of TNFα 
with antibodies using the TMB substrate reagent kit (BD Biosciences) according to 
the manufacturer’s instructions. The absorbance of the samples was measured at 
450 nm with subtraction of absorption values at 570 nm. Quantification of TNFα in 
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each sample was performed by linear regression analysis of the standard curve 
using GraphPad Prism (version 5). Statistical analysis was performed using a one-
way ANOVA test with post-hoc analysis (Tukey’s multiple comparisons test). 
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Figure 1. Co-expression with tHMGR gives enhanced triterpene levels a, 
Biosynthesis of triterpenes occurs via the mevalonate pathway.  b, β-Amyrin content 
of tobacco leaves co-expressing SAD1 β-amyrin synthase with GFP, tHMGR, FPS, 
SQS or SQE (mean, three biological replicates ± s.e; control, GFP only);  *, P < 0.05; 
n.s., not significant.  c, Total ion chromatograms (TICs) for extracts from leaves 
expressing SAD1 with either GFP or tHMGR. d, Oxygenation of the β-amyrin 
scaffold to 12,13-epoxy, 16-hydroxy-β-amyrin (EpHβA) by CYP51H10. e, EpHβA 
content of leaves expressing SAD1 and CYP51H10 with GFP or tHMGR (mean, 
three biological replicates ± s.e.); ***, P < 0.0001.  f, Total ion chromatograms (TICs) 






Figure 2. Generation of gram quantities of triterpene using vacuum infiltration 
a, Vacuum infiltration of N. benthamiana plants.  Plants are retained by a bespoke 
holder, inverted into a bath containing 10 L of A. tumefaciens suspension, and a 
vacuum applied. Upon release of the vacuum the infiltration process is complete.  b, 
GFP expression in leaves from a vacuum-infiltrated plant 5 days after infiltration 
(leaves arranged from top left to bottom right in descending order of their height on 
the plant). The youngest leaves (top left) were formed post-infiltration.  c, β-Amyrin 









Figure 3.  Combinatorial biosynthesis Biosynthesis of oxygenated triterpenes in 
N. benthamiana.  The major products of combinatorial biosynthesis are shown in the 
outer circle. The structures of compounds 11-17 were determined by NMR following 
initial GC-MS analysis (Figs S8-13; Tables S1-8).  Structures 7-10 were inferred by 
GC-MS, based on comparison with previously reported compounds (Table S1; Figs 
S4-7).  GC-MS also revealed a further 30 new unidentified products across the 
different enzyme combinations (Table S1).  Similar results were obtained when β-
amyrin synthase was co-expressed with the different CYP combinations in yeast 




















Figure 4. Evaluation of biological activity a, Compounds used.  b, Anti-
proliferative assays.  IC
50
 values (µM) for the human cancer cell line HL60 are shown 
(means, three biological replicates ± s.d.).  c, Anti-inflammatory activity. TNFα 
release was measured by ELISA following lipopolysaccharide stimulation of THP-1 































11-Oxo-β-amyrin 26.3 ± 1.1
24-Hydroxy-β-amyrin >200
Erythrodiol 23.7 ± 4.9
Oleanolic acid 26.5 ± 6.7
30-Hydroxy-β-amyrin >200
11-Oxo-oleanolic acid 30.6 ± 4.2
Glycyrrhetinic acid 25.7 ± 2.9
11-Oxo,24-hydroxy-β-amyrin >200
Bardoxolone methyl 0.7 ± 0.1
Oleanolic acidErythrodiol
11-Oxo-β-amyrin
















(100 nM). Values are relative to control DMSO-treated cells (means, three biological 






 Transient plant expression technology provides rapid access to diverse 
triterpenes 
 Gram-scale quantities of purified triterpene can be generated 
 Agro-infiltration can be exploited for quick and easy combinatorial 
biosynthesis 
 Bespoke known and new-to-nature compounds can be generated 
 The platform allows isolation of analogs for structure-activity investigations 
 
 
